Chris Qualls Director, Engineering & Technology Boehringer-Ingelheim: Insight into Advanced Manufacturing.

Slides:



Advertisements
Similar presentations
About the Biotech Industry A North Carolina Biotechnology Center survey shows that 70% of biomanufacturing workers are trained at the Community College.
Advertisements

Ferring Controlled Therapeutics
CONTRACT RESEARCH SERVICES 1537 NW 65th Avenue Plantation, FL USA Phone: (954) Fax: (954)
Regulatory Auditing. Audit Areas Management Responsibility Auditing (internal and external) Design Control Document Control Purchasing Control Identification.
Producing a Pharmaceutical or Biopharmaceutical
CSI Biopharmaceutical Manufacturing: How Manufacturing Failures are Investigated Katie Stewart – Technical Training Manager.
Quality by Design: A Challenge to the Pharma Industry CAMP Member Companies March 2002 CAMP.
A MBIO P HARM, Inc. Biopharmaceutical Manufacturing and Services.
Pharmaceuticals Limited India – CIS International Pharma Conference 3-5 th March 2006, Mumbai Prashant Nagre Vice President – API Division.
World Health Organization
Satellite Notification and Acceptance Program (SNAP)
Chemistry, Manufacturing, and Controls (CMC) and Good Manufacturing Practices (GMPs): The Big Picture of a Long-term Commitment Elizabeth Pollina Cormier,
IUA Conference Performance & Sustainability th September 2014 Gerry Collins – Janssen Pharmaceuticals Parenteral Platform Global Lead.
Introduction Opportunity Market potential of recombinant drugs Problem Lack of manufacturing capacity Solution PharmOut: Contract BioManufacturing.
Biopharmaceutical Production Biopharmaceutical development and GMP manufacturing Professionally sound Reliable Innovative Open Respectful.
1. 0ur story 8 of the top 10 Pharmaceutical companies are located in Ireland. 12 out of the top 25 selling drugs are produced in Ireland Exported €50.8.
LIFE SCIENCES Pharmaceutical Manufacturing Chemical & Biosciences Technology QA/QC in Pharmaceutical Industry Applied Biology & Chemistry.
UNIT 3.04 Career Opportunities By PresenterMedia.comPresenterMedia.com.
On the Job Careers in Biomanufacturing. Seizing the Opportunity Bioprocess, pharmaceutical and chemical manufacturing jobs offer unique opportunities.
Personnel Basic Principles of GMP Workshop on
Southern Indiana Life Sciences Training Institute Sengyong Lee Ph.D. Associate Professor/Program Chair Ivy Tech Community College Bloomington, IN
Pharmaceutical Industry and Boehringer Ingelheim Paul Fonteyne Executive Vice President Head of Marketing & Sales, Prescription Medicines Pharmaceutical.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
1 Global New Employee Orientation Workshop Welcome.
Atlantic Canada’s Value Proposition Re$earch Money Conference November, 2007 Halifax, Nova Scotia.
Regulatory Overview.
Challenges to Indian Multinational Cos. P. M. Kelkar 18 th March, 2006 Thorale Bajirao Peshwe Sabhagruha, Thane.
Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.
Corporate Responsibility and Third Party Relationships GSK and Contract Manufacturers James Hagan Vice President Corporate Environment, Health & Safety.
An Amazing Brand Portfolio
3rd Dimension of Product Translation: Industrialization
Abcd Value through Innovation ABCD. Abcd Value Through Innovation Boehringer Ingelheim is committed to becoming the most innovative research, development.
Veiovis LifeSciences Pvt Ltd
CSI Biopharmaceutical Manufacturing: How Manufacturing Failures are Investigated Human Genome Sciences Inc. Katie Stewart – Technical Training Supervisor.
Important informations
1 machan consulting Commercialising the Supply Chain Ian Machan Machan Consulting.
QSR and GLP What exactly are these?.
The Biotech Industry and Careers Why choose a career in Biotechnology? Because you can help save lives, cure diseases, help feed the hungry, help create.
Basic Principles of GMP
THE BIOTECHNOLOGY WORKPLACE. OVERVIEW Biotechnology workplaces Laboratories.
Molecule-to-Market-Place Quality
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
What do we need GMP compliant facility (R1 billion 2008) Flow, segregation, containment, environmental, statutory Modern technologies for raw material,
3M Touch Systems © 3M All Rights Reserved. 3M CONFIDENTIAL Company Overview Date.
ARETA INTERNATIONAL S.r.l. The Reliable Partner for the Development of Biodrugs in the field of Advanced Therapies.
Module 1 Biotechnology Basics Copyright © Texas Education Agency All rights reserved.
Laurie E. Locascio, Ph.D. Director, MML/NIST NIST/MML: Measurement Assurance for Biological Systems.
Producing a Pharmaceutical or Biopharmaceutical The Manufacturing Process.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Bioreactor Market to reach $1.9 billion by 2024.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024
I am in the Biotechnology industry
Author: Nurul Azyyati Sabri
GOOD MANUFACTURING PRACTICE FOR BIOPROCESS ENGINEERING (ERT 425)
נמטוציטים משושנת ים Eli. S Lec. No.2.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Bioreactor Market to surpass.
Biotechnology R&D.
Producing a Pharmaceutical or Biopharmaceutical
VxP Pharma The Pharmaceutical Services Company
Careers in Biomanufacturing
Presentation on Good Manufacturing Practice
DENSO Corporation Organization
Lesson 5: BRITE Seminar: GMP II
Introduction to the Biotechnology Workplace
Introduction to the Biotechnology Workplace
Producing a Pharmaceutical or Biopharmaceutical
MONOJO Biotech Services Centre.
MONOJO Biotech Services Centre.
Producing a Pharmaceutical or Biopharmaceutical
Producing a Pharmaceutical or Biopharmaceutical
Presentation transcript:

Chris Qualls Director, Engineering & Technology Boehringer-Ingelheim: Insight into Advanced Manufacturing

Who is Boehringer-Ingelheim? CA Senate Joint Hearing: Advanced Manufacturing 2 Family-owned global corporation Founded 1885 in Ingelheim, Germany Prescription medicine, consumer healthcare, biopharmaceuticals, pharma chemicals & animal health Employees worldwide: more than 42, production facilities in 13 countries Total revenue: nearly $17 billion (2010) Affiliated companies: 145 in 50 countries March 21, 2012

Our Businesses World net sales by business segments (2010) Total EUR 12,6 billion March 21, CA Senate Joint Hearing: Advanced Manufacturing

Our R&D Focus on six therapeutic areas CA Senate Joint Hearing: Advanced Manufacturing Research AreasExamples of disease areas Respiratory diseases Asthma, COPD, Idiopathic pulmonary fibrosis Cardiometabolic diseases Atherosclerosis, Diabetes, Metabolic syndrome, Thrombo-embolic diseases OncologyLymphomas, Leukaemias, Solid tumours Neurological diseases Alzheimer’s disease, Chronic pain, Migraine, Parkinson’s disease ImmunologyMultiple sclerosis, Psoriasis, Rheumatoid arthritis Infectious diseasesHepatitis C, HIV/AIDS March 21,

We are the Pioneer in Biopharmaceuticals BIBERACH VIENNA FREMONT Research in chicken Interferon 1984 New GMP Biotech plants Biberach/Vienna 1998 Strategic decision for contract manufacturing business 2003/5 Additional new large scale plants Biberach/Vienna 2010 Establishment of global Biopharma Organisation with a global account management structure 2011 Acquisition of US biopharma plant (Fremont) 1963 CA Senate Joint Hearing: Advanced Manufacturing 5 March 21, 2012

6 Our Fremont Facilities 200,000 sq ft of manufacturing B 2 Size 100,000 ft 2 (9,290 m 2 ) Function Offices Process Science labs and Pilot Plant B 3 Size 100,000 ft 2 (9,290 m 2 ) Function Bulk drug substance manufacturing Drug product filling Utilities B 3A Size 10,000 ft 2 (1,310 m 2 ) Function GMP cold room Utilities Maintenance Calibration B 4 Size 100,000 ft 2 (9,290 m 2 ) Function GMP Warehouse Manufacturing  Labeling, Packaging, Inspection Quality Assurance & Records Archive QC Laboratories March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing

Our Workforce at Fremont  300 full-time employees  Average salary $90,000  Nearly 80% have college degrees 25% Masters & PhD level March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing 7

8 Manufacturing at Fremont Manufacturing of clinical and commercial biopharmaceuticals Pilot plant and process development labs Suited for the development and commercialization of therapeutic proteins and antibodies from mammalian host systems Utilized by regional FDA for staff training Boehringer-Ingelheim is one of the largest contract manufacturers in the world March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing

9 Production Capabilities Drug Substance Manufacturing Capabilities BI Fremont East and West Trains are of similar design Inoculum Fermentatio n Downstrea m processing Formulation 1 suite 1x L 2 suites 1 suite Cell Culture Facility "East Train" Cell Culture Facility "West Train" 1 suite 1x L 2 suites 1 suite March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing

10 Bulk Manufacturing Provides Capacity, Capability and Flexibility March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing Four Steps of Production Process 1.Cell Cultivation: Growing &expanding cells to produce product 2.Harvesting: Separate product from cell culture broth 3.Purification: Enriching specified product 4.Fill & Finish: Put the product into a formulation buffer & fill into vial Two separate bulk trains enable concurrent production at clinical or commercial scale. text 12kL 2 C e l l C u l t u r e P u r i f i c a t i o n H a r v e s t EAST WEST 12kl 2kl

Biopharmaceuticals Our Fill & Finish Toolbox 11 Bags Double Chamber Syringe Cartridges / PENs Vials (liquid, lyo)Spray dryingPre-filled Syringe CA Senate Joint Hearing: Advanced Manufacturing March 21, 2012

12 Product Quality: Management Employs Several Functions to Ensure Patient Safety Quality Assurance —Performs Quality oversight for cGMP site operations, disposition, investigations, internal auditing, and management of external inspections Quality Control —Performs cGMP testing of in-process, stability, validation, lot release, and facility support including method validation and transfer Quality Systems —Uses a comprehensive management program to define, implement, monitor, and continuously improve Quality Engineering —Supports continuous improvement by applying quality engineering, Six Sigma, Lean, 5S and project management tools Validation —Ensures facilities, equipment, processes and systems are qualified and validated to current industry practice and regulatory requirements March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing

Enabling Advanced Manufacturing at our Fremont Facility Planned Investment  $100 M Capital Investment of Manufacturing Machinery  $30M Capital Investment of Research and Development machinery  $10M of consumption items for Manufacturing  $1M of consumption items for R&D Production  Technologically complex systems  Innovative products  Manufacturing with high levels of design and precision Special Requirements  Regulated air filtration systems  Specially skilled facility cleaning  Mandated to wear special clothing, masks, etc. Labor & Skill Set  Highly educated  Particular skills/background required March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing 13

Sales & Use Tax March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing 14 Sales & Use TaxCACTOHNY Rate8.75%6.35%6.75%Rate avg 8% Manufacturing Machinery & Equipment Capital Equipment8,750,000Exempt Consumption Items875,000Exempt Research & Development Capital Equipment2,625,000Exempt Consumption Items87,500Exempt67,500Exempt Total Sales & Use Tax12,337,500067,5000

Personal Property Tax March 21, 2012 CA Senate Joint Hearing: Advanced Manufacturing 15 Personal Property TaxCACTOHNY Rate1%Exempt Manufacturing Machinery1,000,000Exempt Research & Development Machinery 10,000Exempt Total Personal Property Tax1,010,000000